O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma
暂无分享,去创建一个
A. Oza | J. Ledermann | R. Coleman | C. Aghajanian | A. Leary | N. Colombo | G. Scambia | S. Goble | A. Clamp | P. Fong | A. Oaknin | J. Weberpals | D. O’Malley | D. Lorusso | A. Dean | L. Maloney | J. Goh | M. A. Gancedo | Robert W. Holloway | Robert W Holloway